Provided by Tiger Trade Technology Pte. Ltd.

PTC Inc

129.29
+0.40000.31%
Volume:279.76K
Turnover:35.84M
Market Cap:14.03B
PE:12.53
High:129.42
Open:127.72
Low:126.79
Close:128.89
52wk High:208.56
52wk Low:108.50
Shares:108.51M
Float Shares:108.19M
Volume Ratio:0.69
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):10.32
EPS(LYR):6.08
ROE:35.05%
ROA:11.54%
PB:4.04
PE(LYR):21.26

Loading ...

Barclays Sticks to Their Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 14

PTC Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 14

Cantor Fitzgerald Sticks to Their Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 13

Bank of America Securities Reaffirms Their Buy Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 13

Ptc Advances Leadership in AI-Driven Design with Launch of Onshape Featurescript Mcp Server

Reuters
·
Aug 13

PTC Advances Leadership in AI-Driven Design with Launch of Onshape Featurescript Mcp Server

THOMSON REUTERS
·
Aug 13

PTC Therapeutics to Acquire ST-920 Fabry Gene Therapy

TIPRANKS
·
Aug 13

PTC Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

Press Release: PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program

Dow Jones
·
Aug 13

PTC Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 11

PTC Inc. Stock Advances 5.9%, Outperforms Peers

Dow Jones
·
Aug 07

PTC Currently up Nine Consecutive Days, on Track for Longest Winning Streak Since December 2020

Dow Jones
·
Aug 05

PTC to Attend Oppenheimer Annual Technology Conference

Reuters
·
Aug 05

PTC Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
Aug 05

PTC Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 04

Barclays Keeps Their Buy Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
Aug 03

PTC (PTC) Is Up 15.8% After Raising 2026 Outlook And Completing $1.57 Billion Buyback

Simply Wall St.
·
Aug 01

PTC is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 01

PTC Therapeutics is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 01

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Regeneron (REGN) and PTC Therapeutics (PTCT)

TIPRANKS
·
Jul 31